Corentec Co

Corentec Co FCF per Share

The Free Cash Flow per Share of Corentec Co (104540.KQ) as of Nov 20, 2026 is 1,788.12 KRW. In the previous year, Free Cash Flow per Share was -996.27 KRW — a change of -279.48% (higher).

FCF per Share

1,788.12KRW

YoY

-279.48%

Last updated:

Free Cash Flow per Share of Corentec Co is 2025 1,788.12 KRW. Free Cash Flow per Share of Corentec Co was 2024 -996.27 KRW. It decreases by -279.48% higher compared to the previous year.

The Corentec Co FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
131.58 KRW
Jan 1, 2019
52.78 KRW
Jan 1, 2020
-860.44 KRW
Jan 1, 2021
-364.44 KRW
Jan 1, 2022
360.05 KRW
Jan 1, 2023
-720.62 KRW
Jan 1, 2024
-996.27 KRW
Jan 1, 2025
1,788.12 KRW
The Corentec Co FCF per Share history
YEARFCF per ShareYoY
1,788.12KRW-279.48%
-996.27KRW+38.25%
-720.62KRW-300.15%
360.05KRW-198.79%
-364.44KRW-57.64%
-860.44KRW-1,730.16%
52.78KRW-59.88%
131.58KRW-116.05%
-819.91KRW-9.54%
-906.36KRW-5.41%
-958.18KRW-40.50%
-1,610.42KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co., Ltd. manufactures and sells artificial articulations, including hip, knee, and spine products. The company offers hip products under the BENCOX brand, featuring primary systems, hemi-arthroplasty systems, and revision systems such as cementless femoral stems and acetabular cups. Knee products are sold under the LOSPA brand, including fixed and mobile primary knee systems and revision systems. Spine products also carry the LOSPA IS brand, comprising pedicle screws and peek cages. Corentec distributes these products domestically and internationally, targeting healthcare providers and hospitals that require orthopedic solutions. The firm’s revenue comes from the sale of hip, knee, and spine products through its BENCOX, LOSPA, and LOSPA IS brand portfolios. Domestic and overseas markets are key segments, with the company focusing on orthopedic surgeons and medical institutions that purchase these specialized medical devices. Corentec’s product lines are designed for both primary and revision surgeries, catering to a broad range of orthopedic needs in the healthcare sector. Corentec Co., Ltd. serves healthcare providers globally, with its BENCOX brand dominating hip product sales and LOSPA/LOSPA IS covering knee and spine solutions. The company’s distribution strategy emphasizes direct sales to hospitals and medical centers, ensuring consistent product availability for surgical procedures. By maintaining distinct brand identities for each product category, Corentec efficiently targets specific medical specialties within the orthopedic market. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Free Cash Flow per Share of Corentec Co is 1,788.12 KRW in 2025.

Free Cash Flow per Share of Corentec Co changed from -996.27 KRW to 1,788.12 KRW, representing a -279.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Corentec Co since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Corentec Co

All Key Metrics — Corentec Co